Structural differences between wild-type and fish eye disease mutant of lecithin:cholesterol acyltransferase

J Biomol Struct Dyn. 2006 Aug;24(1):75-82. doi: 10.1080/07391102.2006.10507101.

Abstract

Fluorescence spectroscopy has been used to investigate the conformational changes that occur upon binding of wild type (WT) and mutant (Thr123Ile) lecithin:cholesterol acyltransferase (LCAT) to the potential substrates (dioleoyl-phosphatidyl choline [DOPC] and high density lipoprotein [HDL]). For a detailed analysis of structural differences between WT and mutant LCAT, we performed decompositional analysis of a set of tryptophan fluorescence spectra, measured at increasing concentrations of external quenchers (acrylamide and KI). The data obtained show that Thr123Ile mutation in LCAT leads to a conformation that is likely to be more rigid (less mobile/flexible) than that of the WT protein with a redistribution of charged residues around exposed tryptophan fluorophores. We propose that the redistribution of charged residues in mutant LCAT may be a major factor responsible for the dramatically reduced activity of the enzyme with HDL and reconstituted high density lipoprotein (rHDL).

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution*
  • Cholesterol, HDL / metabolism
  • Humans
  • Lecithin Cholesterol Acyltransferase Deficiency / genetics*
  • Phosphatidylcholine-Sterol O-Acyltransferase / chemistry*
  • Phosphatidylcholine-Sterol O-Acyltransferase / genetics*
  • Phosphatidylcholine-Sterol O-Acyltransferase / metabolism
  • Spectrometry, Fluorescence
  • Tryptophan / chemistry
  • Tryptophan / genetics

Substances

  • Cholesterol, HDL
  • Tryptophan
  • Phosphatidylcholine-Sterol O-Acyltransferase